Clinical Trials List
2021-11-01 - 2026-12-31
Phase III
Recruiting8
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chun-Hui Lee 未分科
- Kuo-Ting Lee 未分科
- 楊舜如 未分科
- Jui-Hung Tsai 未分科
- Yao-Lung Kuo 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Cheng Huang 未分科
- Ta-Chung Chao 未分科
- 馮晉榮 未分科
- 邱仁輝 未分科
- Chun-Yu Liu 未分科
- 林燕淑 未分科
- 賴亦貞 未分科
- Yi-Fang Tsai 未分科
- Jiun-I Lai 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Chang Yu 未分科
- Mengting Peng 未分科
- 周旭桓 未分科
- Chan-Keng Yang 未分科
- Wen-Ling Kuo 未分科
- Wen-Chi Shen 未分科
- 阮昱翔 Division of Radiology
- 沈士哲 未分科
- Yung-Chang Lin 未分科
- Chun-Hsiu Liu Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Liang-Chih Liu 無
- 黃至豪 無
- Yao-Chung Wu 無
- Chen-Teng Wu 無
- Chih-Jung Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳怡君 無
- 羅喬 無
- 張端瑩 無
- 黃柏翔 無
- 朱筱桑 無
- Wei-Wu Chen 無
- MING-YANG WANG 無
- 林季宏 無
- WEI-LI MA 無
- 林柏翰 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
納入ˋ40 participants
-
Global
納入700 participants
